Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 13 - Issue 10 - October, 2001

Feature

Review
The Renaissance of Directional Coronary Atherectomy: A Second Look From the Inside
08/01/2008
Yasuhiro Honda, MD and Peter J. Fitzgerald, MD, PhD
Yasuhiro Honda, MD and Peter J. Fitzg...
The dawn of atherectomy. The concept of transcatheter atherectomy — removing obstructive tissue by a catheter-based excision technique — was first introduced by Simpson to overcome several unsolved limitations of the conventional...
The dawn of atherectomy. The concept of transcatheter atherectomy — removing obstructive tissue by a catheter-based excision technique — was first introduced by Simpson to overcome several unsolved limitations of the conventional...
The dawn of atherectomy. The...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
Role of Invasive Electrophysiologic Testing in Risk Stratification for Sudden Cardiac Death
08/01/2008
Mohammad Saeed, MD, Munther K. Homoud, MD, Paul J. Wang, PhD, N.A. Mark Estes III, MD, Mark S. Link, MD
Mohammad Saeed, MD, Munther K. Homou...
A comprehensive electrophysiologic study (EPS) is a useful diagnostic tool for the clinical cardiac electrophysiologist in the care of patients. It assists in diagnosing bradyarrhythmias and tachyarrhythmias; it also contributes immensely to...
A comprehensive electrophysiologic study (EPS) is a useful diagnostic tool for the clinical cardiac electrophysiologist in the care of patients. It assists in diagnosing bradyarrhythmias and tachyarrhythmias; it also contributes immensely to...
A comprehensive...
08/01/2008
Journal of Invasive Cardiology
Feature
November 2001 Letter to Readers
08/01/2008
Richard E. Shaw, PhD, FACC
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a special teaching collection on innovative treatments for valvular heart disease, and articles from the special sections...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a special teaching collection on innovative treatments for valvular heart disease, and articles from the special sections...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Feature
Refractory Angina and Anterior Ischemia in a Patient with a Patent Left Internal Mammary Artery Bypass Graft
08/01/2008
James L. Orford, MBChB, MPH, Panayotis Fasseas, MD, Ali E. Denktas, MD, Kevin A. Bybee, MD, Charanjit S. Rihal, MD, David R. Holmes, MD
James L. Orford, MBChB, MPH, Panayot...
Case Description.A 50-year-old man was referred to our institution for evaluation and management of angina pectoris. He had experienced exertional chest pain three years prior to this admission, which had initially been treated medically....
Case Description.A 50-year-old man was referred to our institution for evaluation and management of angina pectoris. He had experienced exertional chest pain three years prior to this admission, which had initially been treated medically....
Case Description.A 50-year-old...
08/01/2008
Journal of Invasive Cardiology
A Randomized Trial of the Low-Molecular-Weight Heparin Certoparin to Prevent Restenosis Following Coronary Angioplasty
08/01/2008
James L. Orford, MBChB, MPH, Panayotis Fasseas, MD, Ali E. Denktas, MD, Kevin A. Bybee, MD, Charanjit S. Rihal, MD, David R. Holmes, MD
James L. Orford, MBChB, MPH, Panayot...
Coronary angioplasty has become a successful and widely used treatment for patients with coronary artery disease since its first clinical application in 1977. However, late (36 month) restenosis rates (20–30%) continue to be the most...
Coronary angioplasty has become a successful and widely used treatment for patients with coronary artery disease since its first clinical application in 1977. However, late (36 month) restenosis rates (20–30%) continue to be the most...
Coronary angioplasty has become...
08/01/2008
Journal of Invasive Cardiology
Self-Expanding Stents for Carotid Interventions: Comparison of Nitinol Versus Stainless-Steel Stents
08/01/2008
Debabrata Mukherjee, MD, *Vidyasagar Kalahasti, MD, *Marco Roffi, MD, *Deepak L. Bhatt, MD, *Samir R. Kapadia, MD, *Christopher Bajzer, MD, *Joel Reginelli, MD, *Khaled M. Ziada, MD, *Kathy Hughes, RN, *Jay S. Yadav, MD
Debabrata Mukherjee, MD, *Vidyasagar...
Angioplasty and stenting are becoming increasingly accepted techniques for the treatment of carotid stenosis. Compared to endarterectomy, carotid stenting is a less invasive procedure that provides an attractive treatment alternative for some...
Angioplasty and stenting are becoming increasingly accepted techniques for the treatment of carotid stenosis. Compared to endarterectomy, carotid stenting is a less invasive procedure that provides an attractive treatment alternative for some...
Angioplasty and stenting are...
08/01/2008
Journal of Invasive Cardiology
Aminophylline Does Not Protect Against Radiocontrast Nephropathy in Patients Undergoing Percutaneous Angiographic Procedures
08/01/2008
Nicolas W. Shammas, MD, Matthew J. Kapalis, Melodee Harris, RN, BSc, Dawn McKinney, MA, Edmund P. Coyne, MD
Nicolas W. Shammas, MD, Matthew J. K...
Radiocontrast nephropathy (RCN) is a well-recognized cause of hospital-acquired renal insufficiency.1 Risk factors for RCN include baseline renal dysfunction, diabetes mellitus, high contrast volume, congestive heart failure, dehydration,...
Radiocontrast nephropathy (RCN) is a well-recognized cause of hospital-acquired renal insufficiency.1 Risk factors for RCN include baseline renal dysfunction, diabetes mellitus, high contrast volume, congestive heart failure, dehydration,...
Radiocontrast nephropathy (RCN)...
08/01/2008
Journal of Invasive Cardiology
Direct Stenting in Angiographically Apparent Thrombus-Containing Lesions
08/01/2008
Timur Timurkaynak, MD, Murat Ozdemir, MD, Atiye Cengel, MD, Mustafa Cemri, MD, Haci Ciftci, MD, Ridvan Yalcin, MD, Bulent Boyaci, MD, Ovsev Dortlemez, MD, Halis Dortlemez, MD
Timur Timurkaynak, MD, Murat Ozdemir...
Although once considered to be a contraindication, accumulating data regarding stenting in thrombogenic milieu [acute myocardial infarction (AMI), unstable angina pectoris] in the presence of angiographically apparent thrombus reveal...
Although once considered to be a contraindication, accumulating data regarding stenting in thrombogenic milieu [acute myocardial infarction (AMI), unstable angina pectoris] in the presence of angiographically apparent thrombus reveal...
Although once considered to be a...
08/01/2008
Journal of Invasive Cardiology

News

Teaching Collection
Innovations in the Treatment of Valvular Disease —
Life-Saving Balloon Mitral Valvuloplasty in Patient with Cardiogenic Shock A
08/01/2008
Jiri Endrys, MD, PhD, Atef G. Habashy, MB, Nasser Hayat, MD, PhD
Jiri Endrys, MD, PhD, Atef G. Habash...
Elective balloon mitral valvuloplasty (BMV), performed over the last 15 years, has been shown to effectively relieve the symptoms of significant mitral stenosis in a selected group of patients.1,2 BMV performed in patients with suitable...
Elective balloon mitral valvuloplasty (BMV), performed over the last 15 years, has been shown to effectively relieve the symptoms of significant mitral stenosis in a selected group of patients.1,2 BMV performed in patients with suitable...
Elective balloon mitral...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Innovations in the Treatment of Valvular Disease — Successful Inoue Balloon Valvotomy in a Difficult Case of Mitral Stenosis Usi
08/01/2008
S. Ramamurthy, MD, DM, V.K. Bahl, MD, DM, S.C. Manchanda, MD, DM
S. Ramamurthy, MD, DM, V.K. Bahl, MD...
Balloon mitral commissurotomy (BMC) using the Inoue balloon catheter is now an established mode of therapy for suitable cases of mitral stenosis with results comparable to closed as well as open surgical commissurotomy.1–3 With growing...
Balloon mitral commissurotomy (BMC) using the Inoue balloon catheter is now an established mode of therapy for suitable cases of mitral stenosis with results comparable to closed as well as open surgical commissurotomy.1–3 With growing...
Balloon mitral commissurotomy...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

November 2001 Volume 13 Issue 10

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement